Reduced Phagocytic Capacity of Blood Monocyte/Macrophages in Tuberculosis Patients Is Further Reduced by Smoking
-
Mahshid Aryanpur
,
Esmaeil Mortaz
,
Mohammad Reza Masjedi
,
Payam Tabarsi
,
Johan Garssen
,
Ian M Adcock
,
Alireza Mozafarian
,
Hooman Sharifi
Abstract
Tuberculosis (TB) and tobacco use are two major alarming global health issues posing immense threats to human populations. Mycobacterium tuberculosis (MTB) by activation of macrophages could induce the sequences of cells activation and releases of inflammatory cytokines such as CXCL-8, Il-12 and TNF-α which in turn induces the immune system network. However no information is available on other activity of cells by MTB and smoking. In the current study we aimed to investigate the serum levels TNF-a, CXCL-8 and phagocytosis capacity in tuberculosis patients with and without smoking. 103 subjects entered the study including 61 new diagnosed pulmonary TB patients (23 smokers and 38 nonsmokers) and 42 control healthy subjects. The phagocytosis of fluorescein isothiocyanate dextran (FITC-dextran) in blood monocytes/macrophages through flowcytometry was assessed. Serum levels of TNF-a and CXCL-8 were analyzed by ELISA methods. A lower percentage of cells from TB patients who smoked [50.29% (43.4-57.2), p<0.01] took up FITC-dextran after 2h compared to non-smoking TB subjects [71.62% (69.2-74.1)] and healthy cases [97.45% (95.9-99.1). Phagocytic capacity was inversely correlated with cigarette smoking as measured by pack years (r=-0.73, p<0.001). The serum levels of TNF-a and CXCL-8 were significantly higher in the TB patients who smoked compared to the TB non-smoker group (p<0.001, p<0.01 respectively). Blood monocytes/macrophages from TB patients have reduced phagocytic capacity which is further reduced in TB patients who smoke. Smoking enhanced serum levels of TNF-a and CXCL-8 suggesting a greater imbalance between the proinflammatory and anti-inflammatory factors in these patients.
Hassmiller KM. The association between smoking and tuberculosis. Salud Publica Mex 2006, 48(suppl 1):S201-16.
2. World Health Organization. Global tuberculosis control: WHO report 2010. World Health Organization, 2010.
3. Crevel R v, Ottenhoff THM, van der Meer JWM. Innate Immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002 Apr; 15(2):294–309.
4. Mortaz E, Adcock I M, Tabarsi P, Masjedi M R, Mansouri D, Velayati A A, et al. Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis. J Clin Immunol 2014; 35:1–10.
5. Mortaz E, Varahram M, Farnia P, Bahadori M, Masjedi MR. New Aspects in Immunopathology of Mycobacterium tuberculosis. ISRN Immunology. 2012.
6. Davies P, Yew W, Ganguly D, Davidow A, Reichman L , Dheda K, et al. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006; 100(4):291-8.
7. Elssner A, carter JE, Yunger TM, Wewers MD. HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest 2004; 125(3):1071–6.
8. Oddo M , Renno T, Attinger A, Bakker T, MacDonald HR ,Meylan PR. Fas Ligand-Induced Apoptosis of Infected Human Macrophages Reduces the Viability of Intracellular Mycobacterium tuberculosis. J Immunol 1998; 160(11):5448-54.
9. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997; 65(1):298-304.
10. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R.Cigarette smoke triggers macrophage adhesion and activation of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 2003; 35(7):697–710.
11. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003 Jul; 109(3):365–37.
12. Pankow W, Neumann K, Rüschoff J, Schröder R, von Wichert P. Reduction in HLA-DR antigen density on alveolar macrophages. Lung 1991; 169(5):255–62.
13. Sköld CM, Lundahl J, Halldén G, Hallgren M, Eklund A.Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages. Clin Exp Immunol 1996; 106(1):108–13.
14. Parihar A, Eubank TD, Doseff AI. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J Innate Immun 2010; 2(3):204–15.
15. Scott Algood HM, Ling Lin P, Flynn JL. Tumor Necrosis Factor and Chemokine Interactions in the Formation and Maintenance of Granulomas in Tuberculosis. Clin Infect Dis 2005; 41:(Suppl 3):S189-93.
16. Parameswaran N, Patial S. Tumor necrosis factor-alpha signaling in macrophages .Crit Rev Eukaryot Gene Expr
2010; 20(2):87–103.
17. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with in- fliximab, a tumor necrosis factor a– neutralizing agent. N Engl J Med 2001; 345(15):1098–
104.
18. Keane J. Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 2004; 39(3):300-2.
19. Miranda M S, Breiman A, Allain S, Deknuydt F, Altare F. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clin Dev Immunol 2012; 2012:139127.
20. Ameixa C, Friedland JS. Interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes is regulated by protein tyrosine kinases but not by ERK1/2 or p38 mitogen-activated protein kinases. Infect Immun 2002; 70(8):4743–6.
21. Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 1998;66(3):1121–6.
22. Wickremasinghe M I, Thomas L H , Friedland JS.Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-κB-dependent network. J Immunol 1999; 163(7):3936–47.
23. KrupaA, Fol M, Dziadek BR, Kepka E, Wojciechowska D, Brzostek A, et al. Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response. Mediators Inflamm 2015;2015:124762.
24. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2(5):372-7.
25. Matsunaga K, Klein TW, Friedman H,Yamamoto Y.Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001;167(11):6518–24.
26. Aoshiba K, Tamaoki J, Nagai A. Acute cigarette smoke exposure induces apoptosis of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2001;281(6):L1392-401.
27. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous Compounds in Tobacco Smoke. Int J Environ Res Public Health 2011; 8(2):613-28.
28. Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. CRC press; 2013.
29. Fowles J, Bates M, Noiton D. The chemical constituents
in cigarettes and cigarette smoke: priorities for harm reduction. Porirua, New Zealand: Epidemiology and Toxicology Group, Institute of Environmental Science and Research Ltd. 2000.
30. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64:111-126.
31. Bothamley G. Smoking and tuberculosis: a chance or causal association? Thorax 2005; 60(7):527-8.
32. Van der Vaart H, Postma D, Timens W, Ten H. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59(8):713-21.
33. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007; 37(6):748-55.
34. World Health Organization. Treatment of tuberculosis:guidelines. World Health Organization; 2010.
35. Mortaz E, Gudarzi H, Tabarsi P, Adcock I M, Masjedi MR, Jamaati HR, et al. Flow Cytometry Applications in the Study of Immunological Lung Disorders. Iran J Allergy Asthma Immunol 2015; 14(1):12-18.
36. Yuan F, Fu X, Shi H, Chen G, Dong P, Zhang W.Induction of Murine Macrophage M2 Polarization by Cigarette Smoke Extract via the JAK2/STAT3 Pathway. PLoS One 2014; 9(9):e107063.
37. Van Amersfoort ES, Van Strijp JA. Evaluation Of a Flow Cytometric Fluorescence Quenching Assay Of Phagocytosis Of Sensitized Sheep Erythrocytes By Polymorphonuclear Leukocytes .Cytometry 1994;
17:(4):294-301.
38. Hashemian SMR, Mortaz E, Tabarsi P, Jamaati H, Maghsoomi Z, Khosravi A et al. Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis. J Inflamm (Lond)2014;11:21.
39. Lozano R, Laghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095–128.
40. World Health Organization. Health statistics and information systems: estimates for 2000–2012: cause- specific mortality. Geneva: WHO; c 2015.
41. Patra J, Jha P, Rehm J, Suraweera W. Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: individual participant data (IPD) meta-analyses of 72,684 individuals in 14 high tuberculosis burden countries. PLoS One 2014; 9(5):e96433.
42. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta- analysis. PLoS Med 2007; 4(1):e20 .
43. Shang S, Ordway O, Henao-Tamayo M, Bai X, Oberley-Deegan R, Shanley C, et al. Cigarette smoke increases susceptibility to tuberculosis—evidence from in vivo and in vitro models. J Infect Dis 2011; 203(9):1240–8.
44. Karavitis J, Kovacs EJ. Macrophage phagocytosis: effects of environmental pollutants, alcohol, cigarette smoke, and other external factors. J Leukoc Biol 2011; 90(6):1065-78.
45. Harris J O, Swenson EW, Johnson J. Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest 1970; 49(11):2086–96.
46. Fullerton DG, Jere K, Jambo K, Kulkarni NS, Zijlstra EE, Grigg J, et al. Domestic smoke exposure is associated with alveolar macrophage particulate load. Trop Med Int Health 2009; 14(3):349–54.
47. Ortega E, Barriga C, Rodriguez AB. Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke. Comp Immunol Microbiol Infect Dis 1994; 17(1):77-84.
48. Lundborg M, lohard U, Johansson A, Eklund A, Falk R, Kreyling W, et al. Phagolysosomal morphology and dissolution of cobalt oxide particles by human and rabbit alveolar macrophages. Exp Lung Res 1995;
21(1):51- 66.
49. Zoppini G, Faccini G, Muggeo M, Zenari L, Falezza G, Targher G. Elevated plasma levels of soluble receptors of TNF-a and their asso- ciation with smoking and microvascular complications in young adults with type 1 diabetes. J Clin Endocrinol Metab 2001;86(8):3805–8.
50. Fernandez-Real J-M, Broch M, Vendrell J, Ricart W.Smoking, fat mass and activation of the tumor necrosis factor-a pathway. Int J Obes Relat Metab Disord 2003;27(12):1552–6.
51. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ,Tarraf H, Davies RJ. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J 1994; 7(12):2109–16.
52. Wilson M, Seymour R, Henderson B. Bacterial perturbation of cytokine networks. Infect Immun 1998;66(6):2401-9.
53. Mueller-Ortiz SL, Wanger AR, Norris SJ. Mycobacterial protein HbhA binds human complement component C3. Infect Immun 2001; 69(12):7501-11.
54. van Zyl-Smit RN, Binder A, Meldau R, Semple PL, Evans A, Smith P, et al. Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages. Thorax 2014; 69(4):363–70.
55. Thillai M, Eberhardt C, Lewin AM, Potiphar L, Hingley- Wilson S, Sridhar S, et al. Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood. PLoS One 2012;7(7):e38083.
56. Martin TR, Goodman RB. Chemokines in acute lung injury. Lung Biology in Health and Disease. 2003;
172:189-220.
57. Krupa A, Fol M, Dziadek B R, Kepka E, Wojciechowska D, Brzostek A, et al. ArticleBinding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response. Mediators Inflamm 2015;2015:124762.
58. Lyons MJ, Yoshimura T, McMurray DN. Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis .Tuberculosis (Edinb)2004; 84(5):283-92.
| Files | ||
| Issue | Vol 15, No 3 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Chemokine CXCL8 Phagocytosis Smoker TNF-alpha Tuberculosis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
